1. Thymoquinone inhibited vasculogenic capacity and promoted mesenchymal-epithelial transition of human breast cancer stem cells
   Sanya Haiaty et al, 2021, BMC Complementary Medicine and Therapies CrossRef
2. Celastrol Suppresses Glioma Vasculogenic Mimicry Formation and Angiogenesis by Blocking the PI3K/Akt/mTOR Signaling Pathway
   Yingjun Zhu et al, 2020, Frontiers in Pharmacology CrossRef
3. Lineage Plasticity in Cancer: The Tale of a Skin-Walker
   Archana P. Thankamony et al, 2021, Cancers CrossRef
4. Systematic identification of cancer-associated-fibroblast-derived genes in patients with colorectal cancer based on single-cell sequencing and transcriptomics
   Jia Zhao et al, 2022, Frontiers in Immunology CrossRef
5. Folic Acid Inhibited Vasculogenic Mimicry in Esophageal Cancer Cell Line Eca-109, the One Target Was EphA2
   YuLing Xu et al, 2022, Nutrition and Cancer CrossRef
6. Therapeutic potential of vasculogenic mimicry in urological tumors
   Xinyu Lin et al, 2023, Frontiers in Oncology CrossRef
7. Metabolic Reprogramming in Gastric Cancer: Trojan Horse Effect
   Yu-Ling Bin et al, 2022, Frontiers in Oncology CrossRef
8. Macrophages in Glioblastoma Development and Therapy: A Double-Edged Sword
   Mengwan Wu et al, 2022, Life CrossRef
9. Pan-cancer dissection of vasculogenic mimicry characteristic to provide potential therapeutic targets
   Haibin Tang et al, 2024, Frontiers in Pharmacology CrossRef
10. COE Inhibits Vasculogenic Mimicry by Targeting EphA2 in Hepatocellular Carcinoma, a Research Based on Proteomics Analysis
    Zewen Chu et al, 2021, Frontiers in Pharmacology CrossRef